Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(3.93)
# 3,022
Out of 5,182 analysts
79
Total ratings
46.84%
Success rate
12.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPS COMPASS Pathways | Reiterates: Buy | $70 | $9.01 | +676.91% | 2 | Apr 28, 2026 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $45 | $3.09 | +1,356.31% | 6 | Apr 27, 2026 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $28.16 | +255.11% | 4 | Apr 20, 2026 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $50 | $24.94 | +100.48% | 3 | Apr 2, 2026 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $27.50 | +81.82% | 3 | Mar 26, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $510 | $296.11 | +72.23% | 5 | Mar 25, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $100 | $74.81 | +33.67% | 6 | Mar 25, 2026 | |
| ATAI AtaiBeckley | Reiterates: Buy | $25 | $4.14 | +503.86% | 3 | Mar 17, 2026 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $25 | $3.76 | +564.89% | 3 | Mar 17, 2026 | |
| ALT Altimmune | Maintains: Buy | $12 → $25 | $2.82 | +786.52% | 3 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $7.13 | +951.89% | 2 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $6.09 | +721.02% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $19.13 | +265.92% | 7 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $0.37 | +1,252.08% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $145 | $86.96 | +66.74% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $10.00 | +100.00% | 3 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $29.44 | +103.80% | 4 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $95 | $5.15 | +1,744.66% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $70 | $21.70 | +222.58% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $70 | $20.71 | +238.00% | 2 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $31.83 | +72.79% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.14 | +7,307.41% | 2 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.47 | +580.27% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $0.87 | +1,049.29% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.52 | +557.89% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $30.70 | +160.59% | 2 | Oct 10, 2025 |
COMPASS Pathways
Apr 28, 2026
Reiterates: Buy
Price Target: $70
Current: $9.01
Upside: +676.91%
NRx Pharmaceuticals
Apr 27, 2026
Reiterates: Buy
Price Target: $45
Current: $3.09
Upside: +1,356.31%
Immunocore Holdings
Apr 20, 2026
Reiterates: Buy
Price Target: $100
Current: $28.16
Upside: +255.11%
Alto Neuroscience
Apr 2, 2026
Reiterates: Buy
Price Target: $50
Current: $24.94
Upside: +100.48%
Assembly Biosciences
Mar 26, 2026
Reiterates: Buy
Price Target: $50
Current: $27.50
Upside: +81.82%
Alnylam Pharmaceuticals
Mar 25, 2026
Reiterates: Buy
Price Target: $510
Current: $296.11
Upside: +72.23%
Arrowhead Pharmaceuticals
Mar 25, 2026
Reiterates: Buy
Price Target: $100
Current: $74.81
Upside: +33.67%
AtaiBeckley
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $4.14
Upside: +503.86%
Voyager Therapeutics
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $3.76
Upside: +564.89%
Altimmune
Mar 16, 2026
Maintains: Buy
Price Target: $12 → $25
Current: $2.82
Upside: +786.52%
Mar 13, 2026
Reiterates: Buy
Price Target: $75
Current: $7.13
Upside: +951.89%
Mar 11, 2026
Reiterates: Buy
Price Target: $50
Current: $6.09
Upside: +721.02%
Mar 10, 2026
Reiterates: Buy
Price Target: $70
Current: $19.13
Upside: +265.92%
Mar 6, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $0.37
Upside: +1,252.08%
Mar 4, 2026
Maintains: Buy
Price Target: $115 → $145
Current: $86.96
Upside: +66.74%
Mar 4, 2026
Maintains: Buy
Price Target: $15 → $20
Current: $10.00
Upside: +100.00%
Mar 3, 2026
Reiterates: Buy
Price Target: $60
Current: $29.44
Upside: +103.80%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $95
Current: $5.15
Upside: +1,744.66%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $70
Current: $21.70
Upside: +222.58%
Mar 2, 2026
Maintains: Buy
Price Target: $35 → $70
Current: $20.71
Upside: +238.00%
Feb 25, 2026
Reiterates: Buy
Price Target: $55
Current: $31.83
Upside: +72.79%
Feb 10, 2026
Reiterates: Buy
Price Target: $10
Current: $0.14
Upside: +7,307.41%
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.47
Upside: +580.27%
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.87
Upside: +1,049.29%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.52
Upside: +557.89%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $30.70
Upside: +160.59%